---All---
  • ---All---
  • Accession
  • Catalog #

ELK1 Antibody (S383) Blocking PeptideSynthetic peptide

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
BP6282a 0.1 mg 400 ul In Stock $ 45.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

ELK1 Antibody (S383) Blocking Peptide - Product info

Primary AccessionP19419
Clone Names109051
Calculated MW44888 Da

ELK1 Antibody (S383) Blocking Peptide - Additional info

Gene ID 2002
Target/Specificity
The synthetic peptide sequence used to generate the antibody AP6282a was selected from the S383 region of human ELK1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Format
Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.
Precautions
This product is for research use only. Not for use in diagnostic or therapeutic procedures.

ELK1 Antibody (S383) Blocking Peptide - Protein Information

Name ELK1
Function
Stimulates transcription. Binds to purine-rich DNA sequences. Can form a ternary complex with the serum response factor and the ETS and SRF motifs of the fos serum response element
Cellular Location
Nucleus.
Tissue Location
Lung and testis.

ELK1 Antibody (S383) Blocking Peptide - Related products

AP3309a: Phospho-ELK1-S383 Antibody

AP3377a: Phospho-ELK1-S389 Antibody

AP3424a: Phospho-ELK1-T417 Antibody

AP6282a: ELK1 Antibody (S383)

AP6282b: ELK1 Antibody (T417)

RI11752: ELK1 predesign siRNA

LY11846a: ELK1 Over-expression Lysate

BP3309a: Phospho-ELK1-S383 Antibody Blocking Peptide

BP3377a: Phospho-ELK1-S389 Antibody Blocking Peptide

BP3424a: Phospho-ELK1-T417 Antibody Blocking Peptide

BP6282a: ELK1 Antibody (S383) Blocking Peptide

BP6282b: ELK1 Antibody (T417) Blocking Peptide

AO1084a: ELK1 Antibody

AO1084b: ELK1 Antibody

AJ1257a: Elk-1 Antibody (C-term)

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

ELK1 is a member of the Ets family of transcription factors and of the ternary complex factor (TCF) subfamily. Proteins of the TCF subfamily form a ternary complex by binding to the the serum response factor and the serum reponse element in the promoter of the c-fos proto-oncogene. The protein is a nuclear target for the ras-raf-MAPK signaling cascade.

REFERENCES

Salinas, S., et al., J. Cell Biol. 165(6):767-773 (2004).Yang, S.H., et al., Mol. Cell 12(1):63-74 (2003).Bebien, M., et al., Oncogene 22(12):1836-1847 (2003).Sharrocks, A.D., Biochem. Soc. Trans. 30(2):1-9 (2002).Murai, K., et al., Mol. Cell. Biol. 22(20):7083-7092 (2002).